The family that owns the drug company at the center of the nation’s opioid problem reached a tentative settlement with thousands of municipal governments and nearly 2 dozen states that sued the pharma industry for its role in creating the crisis; nearly 8 in 10 Americans back legislation to protect people from surprise medical bills; the water crisis in Flint, Michigan, was not only about lead in the water—it was also about a deadly outbreak of Legionnaires’ disease.
The family that owns the drug company at the center of the nation’s opioid problem reached a tentative settlement with thousands of municipal governments and nearly 2 dozen states that sued the pharma industry for its role in creating the crisis, according to various press reports. The New York Times reported that the Sackler family would pay $3 billion in cash over 7 years; STAT News reported that payments could reach up to $12 billion over time. In addition, their company, Purdue Pharma, would file for Chapter 11 bankruptcy; the company would be dissolved, and a new one would be formed to continue selling OxyContin and other medicines, with the profits going to the plaintiffs. But not all states have signed on to the deal, including Massachusetts, New York, New Jersey, Pennsylvania, and Connecticut.
Nearly 8 in 10 Americans support legislation to protect people from surprise medical bills. A new poll from the Kaiser Family Foundation shows that support is spread across all political parties: 84% of Democrats, 78% of independents, and 71% of Republicans. Despite the support, some of the backers of legislation on Capitol Hill worry that lobbying by doctors and hospitals may doom the effort.
The water crisis in Flint, Michigan, was not only about lead in the water—it was also about a deadly outbreak of Legionnaires’ disease, according to an investigation aired by PBS Frontline and reported by The Washington Post. While state health officials set the official death toll for the Legionnaires’ outbreak at 12 people, an investigation found that 115 people in Flint died of nonviral pneumonia.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More